Skip to content

The Origin of Infrapyloric Artery

The Origin of Infrapyloric Artery: an Observational Trial

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03071237
Acronym
IPA-Origin
Enrollment
429
Registered
2017-03-06
Start date
2017-03-04
Completion date
2017-12-31
Last updated
2019-02-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stomach Neoplasm

Keywords

infrapyloric artery, gastric cancer

Brief summary

Infrapyloric artery(IPA) is of great importance for gastric cancer patients. According to previous study, the origin of IPA varies greatly among different studies. This trial aims to tell the distribution of IPA origin in Chinese patients.

Detailed description

Infrapyloric artery(IPA) is of great importance for gastric cancer patients. In early gastric cancer patients, the pylorus-preserving gastrectomy requires the preserving of IPA. In advanced gastric cancer patients, the subgroup of No. 6 lymph node might be associated with IPA. In Japanese Gastric Cancer Association(JGCA) gastric cancer classification guidelines, the No. 6 lymph nodes is defined as lymph nodes along the first branch and proximal part of the right gastroepiploic artery(RGEA) down to the confluence of the right gastroepiploic vein and the anterior superior pancreatoduodenal vein. However,if IPA origins from the gastroduodenal artery(GDA) or anterior superior pancreatoduodenal artery(ASPDA), the lymph nodes along the IPA can not be grouped into the No. 6 lymph nodes. Thus, a new definition of No. 6 lymph nodes is needed on the basis of the origin of IPA. Previous studies about IPA origin are few and the origin of IPA varies greatly among different studies.

Interventions

PROCEDUREGastrectomy

Patients with gastric cancer that needs receiving total or distal gastrectomy. During the surgery, IPA needs to be exposed and transected.

Sponsors

Peking University
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* Patients with gastric cancer who needs to receive total or distal gastrectomy. * Signed informed consent

Exclusion criteria

* IPA not dissected, photo-taken or video-recorded.

Design outcomes

Primary

MeasureTime frameDescription
Distribution of IPA originImmediately after surgeryThe percentage of IPA origin from GDA, ASPDA and RGEA.

Secondary

MeasureTime frameDescription
Reconstruction rate of IPA by CT scanImmediately after the reconstruction of CT scan.The rate of identification of IPA origin by reconstruction of CT scan.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 5, 2026